Evidence map›Paper›PMID 26514602›Full record

ArticleBiochimica et biophysica acta2016

Branched phospholipids render lipid vesicles more susceptible to membrane-active peptides.

Natalie J Mitchell, Pamela Seaton, Antje Pokorny

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antimicrobial Peptides Targeting Gram-Positive Bacteria.Pharmaceuticals (Basel, Switzerland) · 2016
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Natalie J MitchellDepartment of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, NC 28403, United States.
Pamela SeatonDepartment of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, NC 28403, United States.
Antje PokornyDepartment of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, NC 28403, United States. Electronic address: almeidaa@uncw.edu.
University of North Carolina Wilmington · US

Funding

The Impact of Bacterial Fatty Acid Structure on the Activity of Antimicrobial PepR15AI088567 · NIAID · UNIVERSITY OF NORTH CAROLINA WILMINGTON · PI POKORNY ALMEIDA, ANTJE · 2010 to 2010
$216k
NIAID NIH HHS AI088567NIAID NIH HHS R15 AI088567
6 · The paper itself

Abstract

Iso- and anteiso-branched lipids are abundant in the cytoplasmic membranes of bacteria. Their function is assumed to be similar to that of unsaturated lipids in other organisms - to maintain the membrane in a fluid state. However, the presence of terminally branched membrane lipids is likely to impact other membrane properties as well. For instance, lipid acyl chain structure has been shown to influence the activity of antimicrobial peptides. Moreover, the development of resistance to antimicrobial agents in Staphylococcus aureus is accompanied by a shift in the fatty acid composition toward a higher fraction of anteiso-branched lipids. Little is known about how branched lipids and the location of the branch point affect the activity of membrane-active peptides. We hypothesized that bilayers containing lipids with low phase transition temperatures would tend to exclude peptides and be less susceptible to peptide-induced perturbation than those made from higher temperature melting lipids. To test this hypothesis, we synthesized a series of asymmetric phospholipids that only differ in the type of fatty acid esterified at the sn-2 position of the lipid glycerol backbone. We tested the influence of acyl chain structure on peptide activity by measuring the kinetics of release from dye-encapsulated lipid vesicles made from these synthetic lipids. The results were compared to those obtained using vesicles made from S. aureus and Staphylococcus sciuri membrane lipid extracts. Anteiso-branched phospholipids, which melt at very low temperatures, produced lipid vesicles that were only slightly less susceptible to peptide-induced dye release than those made from the iso-branched isomer. However, liposomes made from bacterial phospholipid extracts were generally much more resistant to peptide-induced perturbation than those made from any of the synthetic lipids. The results suggest that the increase in the fraction of anteiso-branched fatty acids in antibiotic-resistant strains of S. aureus is unlikely to be the sole factor responsible for the observed increased antibiotic resistance. This article is part of a Special Issue entitled: Antimicrobial peptides edited by Karl Lohner and Kai Hilpert.

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial ProteinsCell MembraneDrug CompoundingDrug LiberationDrug Resistance, BacterialFluoresceinsFluorescent DyesHemolysin ProteinsKineticsLipid BilayersLiposomesLysophosphatidylcholinesMyristic AcidsPhase Transition1-palmitoyl-2-oleoylglycero-3-phosphoglycerol1-palmitoyl-2-oleoylphosphatidylcholine6-carboxyfluoresceinAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial Proteinsdelta hemolysin protein, Staphylococcus aureusFluoresceinsFluorescent DyesHemolysin ProteinsLipid BilayersLiposomesLysophosphatidylcholinesMyristic AcidsPhosphatidylcholinesPhosphatidylglycerolsWe 201Amphipathic peptidesAntimicrobial peptidesBacterial lipids, branched phospholipids, anteiso, 12-methylmyristic acid, δ-lysinCarboxyfluorescein release

Identifiers

PMID26514602
PMCPMC4809760
OpenAlexW1874515336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.